🇺🇸 FDA
Patent

US 8399512

Biocompatible biodegradable fumagillin analog conjugates

granted A61KA61K47/59A61P

Quick answer

US patent 8399512 (Biocompatible biodegradable fumagillin analog conjugates) held by Mersana Therapeutics, Inc. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mersana Therapeutics, Inc.
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K47/59, A61P, A61P35/00, A61P35/02